Adc Therapeutics Sa (ADCT) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Adc Therapeutics Sa  (NYSE: ADCT)
 

Adc Therapeutics Sa Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Adc Therapeutics Sa's inventory turnover ratio sequentially decreased to 4.17 in the second quarter 2026, unsurprisingly, as the Adc Therapeutics Sa markets continue to deteriorate, and ADCT's faces growing challenges to bring down its inventories. Adc Therapeutics Sa's average inventory processing period in the Jun 30 2026 quarter, has increased to 88 days, from 12 days, in the Mar 31 2026 quarter.

Within Healthcare sector 90 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 142, from total ranking in the first quarter 2026 at 1645.

ADCT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Adc Therapeutics Sa Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ADCT Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 3348.95 % 34.45 % -95.78 % 232.05 % 110.29 %
Y / Y Cost of Sales Growth -56.15 % 18.22 % -20.11 % - 35.42 %
Inventory Turnover Ratio (TTM) 4.17 30.98 32.85 9.48 9.77
ADCT's Total Ranking # 142 # 1645 # 1403 # 1688 # 1527
Average inventory processing period 87 12 11 38 37
Seq. Inventory Growth 1655.16 % 195.79 % -63.32 % 81.12 % -31.58 %
Seq. Cost of Sales Growth -88.39 % -62.47 % 1556.12 % -39.23 % -68.7 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 20
Healthcare Sector # 91
Overall Market # 142

Inventory Turnover Ratio Statistics
High Average Low
39.64 9.25 4.17
(Sep 30 2024)   (Jun 30 2026)



ADCT Company Profile >> Back to ADCT Efficiency Comparisons >> Compare ADCT Inventory Turnover Ratio to its Competitors

Financial Statements
Adc Therapeutics Sa's Inventories $ 5 Millions Visit ADCT's Balance sheet
Adc Therapeutics Sa's Cost of Revenues TTM $ 6 Millions Visit ADCT's Income Statement
What are ADCT's Sales? Visit ADCT's Sales by Segment

Other Inventory Turnover Ratios
Adc Therapeutics Sa's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ADCT's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ADCT's Competitors
Inventory Turnover Ratio for ADCT's Suppliers
Inventory Turnover Ratio for ADCT's Customers

You may also want to know
ADCT's Sales Growth Rates ADCT's Pe Price to earnings ratio ADCT's Receivables Turnover Ratio ADCT's Stock Quote
ADCT's Net Income Growth Rates ADCT's Ps Price to Sales ratio ADCT's Sales per Employee ADCT's Asset Turnover Ratio
ADCT's Net Margin ADCT's Pb Price to Book ratio ADCT's Financial Strength Ratios ADCT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Maravai Lifesciences Holdings Inc   3.22 $ 135.038  Millions$ 42  Millions
Solventum Corporation  3.22 $ 3,421.000  Millions$ 1,061  Millions
Agilent Technologies inc   3.20 $ 3,404.000  Millions$ 1,064  Millions
Mettler toledo International Inc   3.18 $ 1,277.460  Millions$ 401  Millions
Bionexus Gene Lab Corp   3.15 $ 2.362  Millions$ 1  Millions
Zevra Therapeutics Inc   3.14 $ 6.180  Millions$ 2  Millions
Prestige Consumer Healthcare Inc   3.13 $ 513.522  Millions$ 164  Millions
Eton Pharmaceuticals Inc   3.11 $ 44.176  Millions$ 14  Millions
Mimedx Group Inc   3.07 $ 75.981  Millions$ 25  Millions
Revvity Inc  2.98 $ 1,136.473  Millions$ 381  Millions
Amneal Pharmaceuticals Inc   2.98 $ 1,891.689  Millions$ 635  Millions
Akebia Therapeutics Inc   2.96 $ 44.632  Millions$ 15  Millions
Msa Safety Inc  2.92 $ 1,021.036  Millions$ 350  Millions
Ligand Pharmaceuticals Incorporated  2.91 $ 32.387  Millions$ 11  Millions
Logicmark Inc  2.83 $ 3.881  Millions$ 1  Millions
Iovance Biotherapeutics inc   2.81 $ 152.872  Millions$ 54  Millions
Dexcom Inc   2.81 $ 1,864.400  Millions$ 663  Millions
Livanova Plc  2.79 $ 468.065  Millions$ 168  Millions
Merck and Co Inc   2.79 $ 17,996.000  Millions$ 6,447  Millions
Inspiremd Inc   2.78 $ 8.847  Millions$ 3  Millions
Dentsply Sirona Inc   2.77 $ 1,839.000  Millions$ 663  Millions
Ani Pharmaceuticals Inc  2.69 $ 387.398  Millions$ 144  Millions
Neogen Corporation  2.67 $ 461.474  Millions$ 173  Millions
Innoviva Inc   2.65 $ 102.975  Millions$ 39  Millions
International Stem Cell Corporation  2.61 $ 4.285  Millions$ 2  Millions
Biomerica Inc   2.59 $ 4.091  Millions$ 2  Millions
Evofem Biosciences Inc   2.58 $ 4.418  Millions$ 2  Millions
Indivior Pharmaceuticals Inc   2.55 $ 240.000  Millions$ 94  Millions
Nephros Inc   2.54 $ 8.991  Millions$ 4  Millions
Illumina Inc   2.52 $ 1,510.000  Millions$ 599  Millions

Date modified: 2026-09-26T07:39:03+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.